Indicated for small defects.
Cerasorb® Dental M is an exciting development in bone regeneration that provides enhanced porosity for better resorption in most bone grafting and dental implant procedures.
new generation of pure-phase ß-tricalcium phosphate (ßTCP)
Porosity: Cerasorb® M maintains about 65% porosity, allowing bone growth not only from the exterior surface, but from the extensive surface area within the granules; it allows it to be completely resorbed.
Resorption: Cerasorb® M will quickly turn over to quality vital bone within 4-12 months depending on the location and size of the defect and the patient characteristics.
Developed through 20 years of research, Cerasorb produces quality bone without having to harvest an autogenous graft or the risk of disease transmission from cadaveric bone - a growing concern for many patients and clinicians.
Cerasorb® has been the subject in more than 160 leading scientific journals.
Osteoconductive: The capillary effect of the blood mixed with Cerasorb® M promotes osteoblasts to stimulate the initial matrix of bone formation or scaffolding.
Cost effective: Cerasorb provides significant savings when compared to most biologically-based bone grafting materials.
1000-2000 µm: Recommended indication: Large Bony Defects, cysts.
Note: Cerasorb granules to be mixed with the patient's fresh blood from the defect or with venous blood, at about a 1/3 blood to 2/3 ratio.
In addition, the patient's PRP (Platelet-Rich-Plasma) may be admixed.